创新药行业基金

Search documents
热门赛道基金频现清盘风险,什么原因?
证券时报· 2025-08-24 08:13
尽管年内收益率颇高,多只解套的热门赛道基却披露清盘风险。 证券时报·券商中国记者注意到,在行业指数持续拉升之际,多只业绩排名领先的医药基金、军工基金、新消 费基金,反而在净值解套之后迎来较大的赎回压力。 有业绩爆棚的创新药基金并不甘心直接清盘,为此召开持有人大会,寻求修改基金合同终止条款,以保住基金 产品的存续。这凸显出股票基金市场火爆趋势中,各类赛道投资的分歧也在逐步加大。 热门赛道基频现清盘风险 在热门行业的盛夏之际,多只优质赛道基却披露合同终止与清盘风险。 8月21日晚间,华南一家公募公告表示,旗下创新药行业基金为适应市场环境变化,更好地维护基金份额持有 人的利益,决定召开基金份额持有人大会,讨论并审议修改基金合同终止条款的议案。一周多前,该公司提 示,这只创新药行业基金已连续45个工作日低于5000万元,产品面临终止基金合同的风险。 除了创新药行业基金,年内赛道火爆的新消费主题基金,也在市场高温之际反倒出现清盘现象。北方某公募在 近日公告,旗下一只新消费主题基金已触发合同终止程序,截至8月21日,该产品已进入基金财产清算工作。 此外,在中证军工行业指数创出两年新高之际,上海一只军工行业基金披露,因基金 ...
热门赛道基金频现清盘风险,什么原因?
券商中国· 2025-08-24 05:32
尽管年内收益率颇高,多只解套的热门赛道基却披露清盘风险。 券商中国记者注意到,在行业指数持续拉升之际,多只业绩排名领先的医药基金、军工基金、新消费基金,反而在净值 解套之后迎来较大的赎回压力。 有业绩爆棚的创新药基金并不甘心直接清盘,为此召开持有人大会,寻求修改基金合同终止条款,以保住基金产品的存 续。这凸显出股票基金市场火爆趋势中,各类赛道投资的分歧也在逐步加大。 热门赛道基频现清盘风险 在热门行业的盛夏之际,多只优质赛道基却披露合同终止与清盘风险。 8月21日晚间,华南一家公募公告表示,旗下创新药行业基金为适应市场环境变化,更好地维护基金份额持有人的利益, 决定召开基金份额持有人大会,讨论并审议修改基金合同终止条款的议案。一周多前,该公司提示,这只创新药行业基 金已连续45个工作日低于5000万元,产品面临终止基金合同的风险。 除了创新药行业基金,年内赛道火爆的新消费主题基金,也在市场高温之际反倒出现清盘现象。北方某公募在近日公 告,旗下一只新消费主题基金已触发合同终止程序,截至8月21日,该产品已进入基金财产清算工作。 在当下军工股趋势不断升温的背景下,中证军工行业指数年内涨幅接近20%,且随着市场业绩 ...
高位赎回!多只次新基金“叫好不叫座”,什么情况?
券商中国· 2025-07-27 14:41
Core Viewpoint - The article highlights the challenges faced by newly established funds in the context of high investor redemptions, leading to significant fund size reductions despite strong performance in the market [1][2][3]. Fund Redemption Issues - Many newly established funds are experiencing substantial redemptions, with some funds seeing up to 90% of their capital withdrawn, resulting in a shift from large funds to "mini funds" [4][5]. - A specific innovative drug industry fund reported a drop in assets from 47 million yuan at the end of March to 32 million yuan by the end of June, despite achieving a year-to-date return of nearly 50% [3][5]. - Another fund, which was established in late March, saw its assets decrease from over 200 million yuan to 17.52 million yuan, with over 90% of its capital redeemed [5][7]. Performance and Strategy - Despite the challenges, some funds have reported impressive returns, with certain funds in the innovative drug sector achieving returns of 136% and 110% year-to-date [8]. - The article notes that funds are increasingly diversifying their holdings, with some funds in unrelated sectors heavily investing in innovative drug stocks, leading to significant returns [8][9]. - Fund managers are advised to focus on long-term investment strategies and avoid concentrating assets in a single type of fund, especially during the performance verification period of semi-annual reports [9]. Market Outlook - There is a growing sentiment among fund managers regarding the need for a shift between high and low-performing sectors, as the current market shows signs of high concentration and potential volatility [10][11]. - Economic growth is expected to slow down in the second half of the year, leading to further performance differentiation among listed companies [11][12]. - Fund managers emphasize the importance of defensive strategies and caution against excessive risk-taking in the current market environment [12].